文献速递皮肤肿瘤

莫氏手术治疗T1a-T2a侵袭性黑色素瘤后治疗机构特征与总生存期的关联

Association of Treatment Facility Characteristics With Overall Survival After Mohs Micrographic Surgery for T1a-T2a Invasive Melanoma.
PubMed 文献 · JAMA Dermatol · 2021-01-01

该回顾性队列研究纳入2004至2014年美国国家癌症数据库中4062例接受莫氏手术治疗的T1a-T2a非转移性黑色素瘤成人患者,评估治疗机构学术隶属与病例量对总生存期的影响。多变量分析显示,学术中心治疗与死亡风险降低约30%相关(HR 0.730;95%CI 0.596-0.895),前十分位容量机构(≥8例/年)治疗也与生存改善相关(HR 0.795;95%CI 0.648-0.977)。

要点

  • 学术中心接受莫氏手术的早期黑色素瘤患者死亡风险显著低于非学术中心。
  • 前十分位容量机构(≥8例/年)治疗与更好的长期生存相关。
  • 识别并规范化高容量/学术机构的实践可能减少中心间生存差异。

核心结论

  • 在学术中心和前十分位容量机构接受莫氏手术治疗T1a-T2a侵袭性黑色素瘤与改善的长期生存相关。

研究设计与样本

  • 回顾性队列研究,纳入2004至2014年美国国家癌症数据库(NCDB)中4062例接受莫氏手术治疗的T1a-T2a非转移性黑色素瘤成人患者。
  • NCDB包含癌症委员会认证机构的所有可报告病例,估计覆盖美国约50%的新发黑色素瘤。
  • 采用Cox比例风险模型进行多变量生存分析。

主要发现

  • 研究人群包括4062例患者(2213例[54.5%]男性;中位[SD]年龄60[16.3]岁),在462个中心接受治疗。
  • 62个中心为前十分位容量机构(TDVF),共治疗1757例患者(61.9%)。
  • 大多数TDVF为学术机构(37/62[59.7%])。
  • 多变量分析中,学术中心治疗与死亡风险降低近30%相关(HR 0.730;95%CI 0.596-0.895)。
  • 另一分析中,TDVF治疗也与生存改善相关(HR 0.795;95%CI 0.648-0.977)。

临床怎么用

  • 对于T1a-T2a侵袭性黑色素瘤的莫氏手术,可优先考虑学术中心或年病例量≥8例的高容量机构。
  • 借鉴高容量/学术机构的诊疗流程可能有助于改善患者生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Early-stage melanoma, among the most common cancers in the US, is typically treated with wide local excision. However, recent advances in immunohistochemistry have led to an increasing number of these cases being excised via Mohs micrographic surgery (MMS). Although studies of resections for other cancers have reported that facility-level factors are associated with patient outcomes, it is not yet established how these factors may affect outcomes for patients treated with Mohs micrographic surgery. OBJECTIVE: To evaluate the association of treatment center academic affiliation and case volume with long-term patient survival after MMS for T1a-T2a invasive melanoma. DESIGN, SETTING, AND PARTICIPANTS: In a retrospective cohort study, 4062 adults with nonmetastatic, T1a-T2a melanoma diagnosed from 2004 to 2014 and treated with MMS in the National Cancer Database (NCDB) were identified. The NCDB includes all reportable cases from Commission on Cancer-accredited facilities and is estimated to capture approximately 50% of all incident melanomas in the US. Multivariable survival analyses were conducted using Cox proportional hazards models. Data analysis was conducted from February 27 to August 18, 2020. EXPOSURES: Treatment facility characteristics. MAIN OUTCOMES AND MEASURES: Overall survival. RESULTS: The study population included 4062 patients (2213 [54.5%] men; median [SD] age, 60 [16.3] years) treated at 462 centers. Sixty-two centers were top decile-volume facilities (TDVFs), which treated 1757 patients (61.9%). Most TDVFs were academic institutions (37 of 62 [59.7%]). On multivariable analysis, treatment at an academic center was associated with a nearly 30% reduction in hazard of death (hazard ratio, 0.730; 95% CI, 0.596-0.895). In a separate analysis, treatment at TDVFs was also associated with improved survival (hazard ratio, 0.795; 95% CI, 0.648-0.977). CONCLUSIONS AND RELEVANCE: In this cohort study, treatment of patients with T1a-T2a invasive melanoma excised with MMS at academic and top decile-volume (≥8 cases per year) facilities was associated with improved long-term survival compared with those excised by MMS at nonacademic and low-volume facilities. Identification and protocolization of the practices of these facilities may help to reduce survival differences between centers.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Cheraghlou S, Christensen SR, Leffell DJ, et al. Association of Treatment Facility Characteristics With Overall Survival After Mohs Micrographic Surgery for T1a-T2a Invasive Melanoma. JAMA Dermatol. 2021. PMID: 33787836. doi:10.1001/jamadermatol.2021.0023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。